Northern Trust Corp Avalo Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$3.0 - $10.45 $1.25 Million - $4.37 Million
-418,208 Reduced 78.22%
116,463 $58,000
Q1 2022

May 13, 2022
BUY
$7.57 - $21.72 $8,274 - $23,739
1,093 Added 0.2%
534,671 $388,000
Q4 2021

Feb 08, 2022
BUY
$19.68 - $28.68 $320,311 - $466,795
16,276 Added 3.15%
533,578 $907,000
Q3 2021

Nov 15, 2021
BUY
$26.16 - $40.68 $13.5 Million - $21 Million
517,302 New
517,302 $1.13 Million

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $91.1M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email